Request Demo
Last update 13 Jun 2026
CGT-6321
Last update 13 Jun 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms CGT 6321, CGT-6321, CGT6321 |
Target |
Action antagonists |
Mechanism FGFRs antagonists(Fibroblast growth factor receptors antagonists), VEGFR antagonists(Vascular endothelial growth factor receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with CGT-6321CTR20220319
评价CGT-6321片在晚期实体瘤患者中的安全性、耐受性、药代动力学特征及有效性的多中心、开放、剂量递增与扩展的Ia/Ib期临床试验
[Translation] A multicenter, open-label, dose-escalation and expansion phase Ia/Ib clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and efficacy of CGT-6321 tablets in patients with advanced solid tumors
100 Clinical Results associated with CGT-6321
Login to view more data
100 Translational Medicine associated with CGT-6321
Login to view more data
100 Patents (Medical) associated with CGT-6321
Login to view more data
100 Deals associated with CGT-6321
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 27 Jun 2022 | |
| Hepatocellular Carcinoma | Phase 1 | China | 27 Jun 2022 | |
| Stomach Cancer | IND Approval | China | 19 Oct 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free